Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
09/2010
09/01/2010CN1925898B Antibody purification technique
09/01/2010CN101821623A Materials and methods for sperm sex selection
09/01/2010CN101821410A Gene silencing of the brother of the regulator of imprinted sites (BORIS)
09/01/2010CN101821394A CHO-K1 cell line
09/01/2010CN101821292A Combination therapy with type i and type ii anti-cd20 antibodies
09/01/2010CN101821291A Compositions and methods for use for antibodies against sclerostin
09/01/2010CN101821290A Influenza virus haemagglutinin-specific monoclonal antibodies
09/01/2010CN101821289A Methods for recombinant manufacturing of anti-rsv antibodies
09/01/2010CN101821288A Covalent diabodies and uses thereof
09/01/2010CN101821287A Interferon fusion proteins
09/01/2010CN101820911A Humanized antibodies to amyloid beta
09/01/2010CN101820910A Antibodies binding to an intracellular prl-1 or prl-3 polypeptide
09/01/2010CN101820894A VHZ for diagnosis and treatment of cancer
09/01/2010CN101818134A ppGalNAc-T20 antigen and preparation method of polyclonal antibody thereof
09/01/2010CN101818129A Hybridoma cell line for anti-African swine fever virus monoclonal antibody and monoclonal antibody secreted thereby
09/01/2010CN101817882A Light-chain variable region and heavy-chain variable region of FMU-EPCAM-4E4 monoclonal antibody
09/01/2010CN101817881A Light-chain variable region and heavy-chain variable region of FMU-EPCAM-4F6 monoclonal antibody
09/01/2010CN101817880A Immune affinity chromatography purification method for specific egg yolk immunoglobulins
09/01/2010CN101816792A Combinations comprising epothilones and pharmaceutical uses thereof
09/01/2010CN101186648B Pseudomonas aeruginosa resisting Fab' fragment
08/2010
08/31/2010USRE41595 Application of hydrophobic interaction chromatography combination chromatography to the purification of antibody molecule proteins, for purifying monomeric IgG antibody from a mixture of monomeric IgG antibody and at least one of immunoglobulin aggregates; biological substance purification
08/31/2010US7786286 Microorganismal, outer-membrane, enzymatic polypeptide for use in developing vaccine for prevention and treatment of nesserial infection
08/31/2010US7786279 Nucleic acid molecules, polypeptides, antibodies and compositions for treating and detecting influenza virus infection
08/31/2010US7786274 Anti-IL-20 antibody and its use in treating IL-20 associated inflammatory diseases
08/31/2010US7786273 free of a denaturing reagent and comprising of an antibody that binds to a respiratory syncytial virus (RSV) antigen, a human metapneumovirus (hMPV) antigen, integrin alpha v beta 3, CD2, CD19, an Eph receptor, or to IL-9
08/31/2010US7786272 bind to biomarker overexpressed in colon or lung tumor cells
08/31/2010US7786271 Antibodies that inhibit TSLP activity
08/31/2010US7786269 The antibodies or fragments specifically bind to an extracellular epitope of an Epstein Barr Virus latent membrane protein; anticarcinogenic agents; cancer vaccines
08/31/2010US7786268 Anti-IP-10 antibodies and methods of use thereof
08/31/2010US7786267 Multivariable antigens complexed with targeting humanized monoclonal antibody
08/31/2010US7786266 Desmocollin 2 (DSC2) specific immunoglobulin for use in prevention and treatment of cell proliferative disorders
08/31/2010US7786265 Modulation of body weights; dietetics; eating disorders; for diagnostic and therapeutic implications in homeostasis of body weight and adipose tissue mass
08/31/2010US7786264 Monoclonal antibody against hepatitis E virus or its fragment with binding activity and use thereof
08/31/2010US7786263 Human T1R2 taste receptor polypeptides
08/31/2010US7786257 Lymphocyte receptors peptide for use as tool in prevention and treatment of infection, autoimmune and cell proliferative disorders; mimetics
08/31/2010US7786255 Poly-N-acetyl glucosamine (PNAG/dPNAG)-binding peptides and methods of use thereof
08/31/2010US7786086 at least one aromatic amino acid (phenylalanine); hollow and fibrillar peptide; macroscopic and microscopic articles; self-assembled; 9-fluorenylmethyloxycarbonyl (Fmoc) and benzyloxycarbonyl (Cbz); slow release of drug, nucleic acid molecule or a polypeptide; antibody
08/31/2010US7786081 Peptide composition
08/31/2010US7786047 an immunoglobulin having determined antigen specificity, and having a variable fragment which is derived from a so-called heavy-chain immunoglobulin having two heavy polypeptide chains capable of recognizing and binding one or several antigens and which is further naturally devoid of light chains
08/31/2010US7785903 Variable domain library and uses
08/31/2010US7785873 Antigen arrays for treatment of bone disease
08/31/2010US7785859 Methods for displaying (poly)peptides/proteins on bacteriophage particles via disulfide bonds
08/31/2010US7785855 Nucleic acids encoding polypeptides having amylase activity and methods of making and using them
08/31/2010US7785853 Comprises heat resistant enzymatic polypeptide for bioremediation of plant biomass and pollution control; reuse
08/31/2010US7785849 Cyclic nucleotide-specific phosphodiesterases from Leishmania and uses thereof
08/31/2010US7785829 polynucleotide encoding a soluble polypeptide; for decreasing inhibition of axonal growth of a central nervous system neuron; neurological diseases, disorders and injuries such as spinal cord injury
08/31/2010US7785816 Antibodies against cancer antigen TMEFF2 and uses thereof
08/31/2010US7785812 Chemotherapy potentiation; drug discovery and design
08/31/2010US7785811 Using lutetium label probes to detect tumor secreted antigens and diagnose/prognose cell proliferative disorders
08/31/2010US7785804 Mammalian CX3C chemokine antibodies
08/31/2010US7785803 Antibody diagnostic kits and methods of use
08/31/2010US7785801 Identification of surface-associated antigens for tumor diagnosis and therapy
08/31/2010US7785791 Polypeptide variants with altered effector function
08/31/2010US7785777 conducting a bioassay on a DNA sample or an RNA sample, to determine the presence or absence of gene mutations associated with a genetic disorder with clinical features including exocrine pancreatic insufficiency, haematological dysfunction and skeletal abnormalities
08/31/2010US7785603 Polynucleotide comprising a first nucleic acid fragment which encodes at least 20 contiguous amino acids of an influenza virus polypeptide, wherein codons of nucleic acid fragment are optimized for expression in humans; enhancing immune response of vertebrate in need of protection against IV infection
08/31/2010US7785599 Albumin fusion proteins
08/31/2010US7785594 antihemophilic factor monoclonal antibodies comprising an immunoglobulin heavy chain and light chain amino acid sequences, with modified by enzymatic deglycosylation or by site directed mutagenesis, used for treating hemostasis disorders; anticoagulants
08/31/2010US7785593 Antibody (11C7) anti nogo a and its pharmaceutical use
08/31/2010US7785592 Stabilized liquid anti-RSV antibody formulations
08/31/2010US7785591 Identification and characterization of function-blocking anti-ED-B-fibronectin antibodies
08/31/2010US7785590 Monoclonal antibody against interleukin-13 receptor alpha 1 (IL-13Ra1)
08/31/2010US7785589 biological fragments comprising polypeptides, in a combination with phosphatides, used for for immunization or treatment of ischemic cardiovascular disorders, in humans
08/31/2010US7785588 Anti-neurturin receptor-A antibody compositions comprising cytokines or neurotrophic factors
08/31/2010US7785587 Mixture of corticosteroid and transforming growth factor inhibitor
08/31/2010US7785586 Capable of binding with a wild type HBsAg antigen and with at least one, preferably at least two or more, mutated forms of the HBsAg antigen
08/31/2010US7785571 Treatment of fungal infections
08/31/2010CA2389582C Production of mammary secretion antibodies in farm animals
08/31/2010CA2323743C Urokinase plasminogen activator receptor as a target for diagnosis of metastases
08/31/2010CA2281262C Anti-human medullasin monoclonal antibody, process for producing the same and immunoassay using the same
08/31/2010CA2217871C Altered polypeptides with increased half-life
08/31/2010CA2190371C Receptor for oncostatin m
08/26/2010WO2010096838A2 Proproteins and methods of use thereof
08/26/2010WO2010096470A2 Method for inhibiting neurodegeneration
08/26/2010WO2010096434A2 Specific binding proteins and uses thereof
08/26/2010WO2010096418A2 Antibody molecules having specificity for human ox40
08/26/2010WO2010095917A1 Monoclonal antibodies against vaginolysin
08/26/2010WO2010095673A1 Cellulose gel for purification of immunoglobulin
08/26/2010WO2010095461A1 Novel monoclonal antibody, and use thereof
08/26/2010WO2010095455A1 Hypo-immunogenic streptavidin and use thereof
08/26/2010WO2010095270A1 Anti-human α9 integrin antibody and use thereof
08/26/2010WO2010095031A2 Humanized antibodies that bind to cd19 and their uses
08/26/2010WO2010094981A2 Antibody therapy
08/26/2010WO2010094970A1 Antibodies to clostridium difficile toxins
08/26/2010WO2010094906A1 The stabilisation of proteins
08/26/2010WO2010094901A1 Means for purifying a protein of blood plasma and methods for implementing same
08/26/2010WO2010094722A2 Improved anti-serum albumin binding variants
08/26/2010WO2010094720A2 Improved anti-tnfr1 polypeptides, antibody variable domains & antagonists
08/26/2010WO2010094499A1 Methods and compositions for diagnosis and treatment of cancer
08/26/2010WO2010094475A1 Method for obtaining immunoglobulin encoding nucleic acid
08/26/2010WO2010094463A1 Means and methods for manufacturing highly pure neurotoxin
08/26/2010WO2010073104A3 Improving cognitive function
08/26/2010WO2010053987A3 Monoclonal antibody production in b cells and uses therof
08/26/2010WO2010038974A3 Composition and kit for diagnosing immunoglobulin a nephropathy and tgbm nephropathy
08/26/2010WO2010004434A3 Method of promoting neurogenesis
08/26/2010WO2010002478A4 Glycopeptide and uses thereof
08/26/2010WO2009140469A3 Dosage regimen comprising ap02l/trail, anti-vegf / anti-cd20 and chemotherapy to treat nsclc or non-hodgkin's lymphoma, respectively
08/26/2010WO2009140177A3 Anti-fn14 antibodies and uses thereof
08/26/2010WO2009081285A3 Hepatitis c virus antibodies
08/26/2010WO2009055524A8 Methods of inhibiting viral infection
08/26/2010US20100218267 Methods for Producing Antibodies
1 ... 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 ... 1494